Dr. Madhu Gargesha of BioInVision presented a paper titled “MSC pre-treatments lead to better cell survival in mouse models of liver disease: A CryoViz Study” at the American Association of Immunologists (AAI) 2016 Conference in Seattle, Washington, USA, May 13-16 2016. The presentation was very well received and generated a lot of interest in the MERLIN project. You can find more details about the Conference here.
- RT @EU_Health: Monitoring the #safety of #blood, #tissues and #cells in the EU: > 25 million donations of blood & > 2 million units of ti… Time ago 2 Days via Twitter Web Client
- Data continues to be held by the study team and is only shared with data requestors following a successful data acc… t.co/FDNuFc04QC Time ago 3 Days via Hootsuite
- @RAIScuola Time ago 4 Days via Hootsuite
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.